Literature DB >> 21971179

The HIF-1α-c-Myc pathway and tumorigenesis: evading the apoptotic gate-keeper.

Nicole Fer1, Giovanni Melillo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21971179      PMCID: PMC3356795          DOI: 10.4161/cc.10.19.17049

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  8 in total

Review 1.  HIF-1: a target for cancer, ischemia and inflammation--too good to be true?

Authors:  Giovanni Melillo
Journal:  Cell Cycle       Date:  2004-02       Impact factor: 4.534

2.  Requirement of evading apoptosis for HIF-1α-induced malignant progression in mouse cells.

Authors:  Masami Hayashi; Yoo Young-Gun Yoo; Jared Christensen; L Eric Huang
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

3.  HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression.

Authors:  Minori Koshiji; Kenneth K-W To; Stefanie Hammer; Kensuke Kumamoto; Adrian L Harris; Paul Modrich; L Eric Huang
Journal:  Mol Cell       Date:  2005-03-18       Impact factor: 17.970

4.  HIF-1α confers aggressive malignant traits on human tumor cells independent of its canonical transcriptional function.

Authors:  Young-Gun Yoo; Jared Christensen; L Eric Huang
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

5.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.

Authors:  T G Graeber; C Osmanian; T Jacks; D E Housman; C J Koch; S W Lowe; A J Giaccia
Journal:  Nature       Date:  1996-01-04       Impact factor: 49.962

Review 6.  The interplay between MYC and HIF in cancer.

Authors:  Chi V Dang; Jung-whan Kim; Ping Gao; Jason Yustein
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

Review 7.  Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics.

Authors:  G L Semenza
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

8.  HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity.

Authors:  John D Gordan; Jessica A Bertout; Cheng-Jun Hu; J Alan Diehl; M Celeste Simon
Journal:  Cancer Cell       Date:  2007-04       Impact factor: 31.743

  8 in total
  6 in total

1.  C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.

Authors:  Xian Lin; Ran Sun; Xiulan Zhao; Dongwang Zhu; Xueming Zhao; Qiang Gu; Xueyi Dong; Danfang Zhang; Yanhui Zhang; Yanlei Li; Baocun Sun
Journal:  J Mol Med (Berl)       Date:  2016-08-19       Impact factor: 4.599

2.  The "Sharp" blade against HIF-mediated metastasis.

Authors:  Ivano Amelio; Gerry Melino
Journal:  Cell Cycle       Date:  2012-11-27       Impact factor: 4.534

3.  Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha.

Authors:  Chao Zhang; Chunzhang Yang; Michael J Feldman; Herui Wang; Ying Pang; Dominic M Maggio; Dongwang Zhu; Cody L Nesvick; Pauline Dmitriev; Petra Bullova; Prashant Chittiboina; Roscoe O Brady; Karel Pacak; Zhengping Zhuang
Journal:  Oncotarget       Date:  2017-05-23

4.  Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?

Authors:  Marco Tafani; Bruna Pucci; Andrea Russo; Luana Schito; Laura Pellegrini; Giulietta A Perrone; Lidia Villanova; Luisa Salvatori; Linda Ravenna; Elisa Petrangeli; Matteo A Russo
Journal:  Front Pharmacol       Date:  2013-02-12       Impact factor: 5.810

5.  Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions.

Authors:  Mikhail V Blagosklonny
Journal:  Oncotarget       Date:  2012-12

6.  Cobalt Chloride Induced Apoptosis by Inhibiting GPC3 Expression via the HIF-1α/c-Myc Axis in HepG2 Cells.

Authors:  Yaoyao Tong; Kun Tong; Qinghong Zhu; Yuqin Wu; Yi Yang; Jicai Zhang; Pei Hu; Shirong Yan
Journal:  Onco Targets Ther       Date:  2019-12-05       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.